Osteotech coverage initiated by Emerging Growth

Osteotech, Inc. coverage was initiated by Emerging Growth Equities, Ltd. at a hold rating and a $6 price target. The company is among the three largest suppliers of demineralized bone matrix, a product used to promote bone healing in orthopedic, spinal, maxillofacial and dental surgery. Emerging Growth said it believes fourth-quarter results will reflect operating difficulties and noncash charges, which should provide investors the chance to buy the stock at favorable prices. Shares of the Eatontown, N.J., biopharmaceutical company were down 32 cents, or 5.38%, at $5.63 on volume of 273,775 shares versus the three-month running average of 133,522 shares. (Nasdaq: OSTE)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.